Bioanalytical services, immunoassays, cell-based assays
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
50
NCT05310734
PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies
Phase: Phase 4
Role: Collaborator
Start: Mar 4, 2022
Completion: Mar 31, 2026
Loading map...